title: Unexpected hyperpigmentation following intralesional bleomycin injection.
authors.forename: D C G
authors.initials: DC
authors.lastname: Sainsbury
authors.forename: G
authors.initials: G
authors.lastname: Kessell
authors.forename: A
authors.initials: A
authors.lastname: Guhan
authors.forename: A
authors.initials: A
authors.lastname: Fall
authors.forename: V
authors.initials: V
authors.lastname: Miller
authors.forename: M R
authors.initials: MR
authors.lastname: Abouzeid
authors.forename: T
authors.initials: T
authors.lastname: Muir
mesh_terms: D000328:Adult; D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000175:diagnosis; D015552:Injections, Intralesional; D008297:Male; D018570:Risk Assessment; D012494:Sampling Studies; D054079:Vascular Malformations / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D001761:Bleomycin